EU countries agree on ‘key pillars’ of health union

On Monday, October 24th, representatives of the EU member states passed three final regulations to complete the European Health Union, which are to come into force in November, Euractiv reports (link in German).

The latest building blocks of the European Health Union relate to the regulation on substantial cross-border health threats, the regulation extending the mandate of the European Center for Disease Prevention and Control (ECDC) and the emergency framework regulation, which provides the EU with additional powers to Health Emergencies Crisis Preparedness and Response Authority (HERA).

“The key pillars of our European Health Union are now in place,” Health Commissioner Stella Kyriakides said in a statement , adding that these are “additional tools to act quickly and respond with determination and unity to emerging health crises.”

In addition to the three new regulations, the regulation extending the mandate of the European Medicines Agency (EMA) has been in force since March of this year.

The four regulations form the package of the European Health Union, first presented by the European Commission on 11 November 2020 in response to the coronavirus pandemic and future public health emergencies.

Related News

All News

Willum Þór: The question remains if our healthcare system is sustainable

On January 1st, Iceland took over the Presidency of the Nordic Council of Ministers. This intergovernmental organisation plays an important role in promoting innovations, health data integration, and cooperation between all major stakeholders in the Nordic healthcare. The Icelandic Health Minister elaborates on his vision to future health in the Nordic region, the Nordic strengths, Iceland’s plans for the Presidency with regards to health innovations, and the coming collaboration with Copenhagen Institute for Futures Studies

CIFS ran an all-day session at the Week of Health and Innovation (WHINN) in Odense

Copenhagen Institute for Futures Studies ran an all-day session at the annual Week of Health and Innovation (WHINN) in Odense, Denmark. CIFS’ program attracted over 40 experts from health and data organisations. We presented strategic foresight and futures studies in the health sector, concepts that are used to reimagine the future of the health sector, such as the Humanome and decentralised clinical trials. Also, we had a panel discussion on the newly started Phase V project on decentralised clinical trials, where CIFS is a contributing partner